NervGen Pharma Corp. Common stock
NGEN | NASDAQ
$1.45
+$0.08 (+5.84%)
Nov 2, 2026, 10:41 AM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -29.99M | -1.7M | -31.7M | -4.16M | -9.15M | -3.93M | -8.6M | -5.29M | -7.82M | -2.35M | -8.61M | -4.29M | -4.76M | -4.71M | -5.89M | -3.46M | -6.32M | -4.96M | -4.18M | -3.59M | -2.73M | -2.25M |
Depreciation & Amortization | 14.32K | 14.18K | 25.84K | 13.97K | 14.02K | 13.87K | 15.8K | 14.63K | 15.02K | 38.37K | 38.63K | 36.51K | 34.98K | 34.76K | 34.45K | 34.42K | 34.21K | 11.37K | 11.29K | 10.85K | 10.56K | 9.98K |
Stock-Based Compensation | n/a | n/a | 5.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -710.77K | -1.86M | 29.02K | -51.73K | 559.44K | 272.44K | 1.15M | -499.44K | 413.26K | -61.89K | 520.46K | 42.31K | 368.79K | -949.1K | 1.02M | -629.92K | 1.74M | -58.37K | 174.26K | 340.49K | -200.36K | 118.59K |
Other Non-Cash Items | 24.99M | -4.77M | 16.11M | -878.26K | 4.65M | -536.88K | 4.19M | 22.9K | 3.21M | -1.12M | 5.19M | 2.77M | 2.31M | 905.01K | -174.89K | -774.53K | 873.03K | 792.04K | 1.14M | 1.21M | 838K | 801.2K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -820.18K | -1.87M | 42.19K | -299.34K | 797.41K | 353.5K | 742.79K | -494.34K | 415.28K | 175.16K | 293.56K | 59.04K | 418.85K | -1.01M | 1.02M | -560.29K | 1.72M | -64.23K | 152.07K | 356.96K | -226.22K | 148.6K |
Operating Cash Flow | -5.81M | -8.34M | -10.13M | -5.33M | -3.68M | -4.1M | -3.66M | -5.74M | -4.18M | -3.25M | -3.09M | -1.42M | -2M | -4.78M | -5.01M | -4.76M | -3.69M | -4.22M | -2.88M | -2.01M | -2.11M | -1.29M |
Capital Expenditures | n/a | 4.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.67K | -2.94K | n/a | n/a | -5.67K | -9.99K | -5.39K | n/a | 39.53K | -42.28K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 2.55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | -79.79 | 8.55K | -54.18K | 25.27K | 25.35K | 25.09K | 58.83K | 33.59K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | 100.93K | n/a | n/a | n/a | -33.62K | -8.4K | 8.4K | n/a | n/a | -135.35K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -79.79 | 8.55K | 46.75K | 25.27K | 25.35K | 25.09K | 25.21K | 25.19K | 8.4K | n/a | n/a | -138.02K | -2.94K | 2.55K | n/a | -5.67K | -9.99K | -5.38K | n/a | -2.75K | -42.28K | n/a |
Debt Repayment | n/a | n/a | -100.93K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 81 | -8.55K | -838.6K | -25.27K | -25.35K | -25.09K | -25.21K | -25.19K | -25.21K | -25.28K | -25.23K | -25.15K | -25.22K | -25.23K | -25.01K | -24.99K | -25.23K | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | 80.19M | 2.83M | 18.67M | 996.61K | 4.78M | 1.27M | 309.79K | 269.3K | 111.2K | 22.04M | 74.78K | 72.15K | 253.71K | 365.29K | 78.98K | 19.68M | 2.56M | 128.15K | 11.68M | 2.8M | 4.51M | 700.65K |
Net Cash Flow | 70.07M | -5.91M | 13.91M | -4.68M | 1.99M | -2.78M | -5.07M | -5.24M | -4.05M | 18.42M | -2.77M | -1.69M | -1.58M | -4.38M | -4.64M | 15.04M | -1.55M | -3.91M | 8.77M | 708.14K | 2.44M | -536.16K |
Free Cash Flow | -5.81M | -8.34M | -10.13M | -5.33M | -3.68M | -4.1M | -3.66M | -5.74M | -4.18M | -3.25M | -3.09M | -1.43M | -2M | -4.78M | -5.01M | -4.77M | -3.7M | -4.23M | -2.88M | -1.97M | -2.15M | -1.29M |
Adj. Free Cash Flow | -5.81M | -8.34M | -15.52M | -5.33M | -3.68M | -4.1M | -3.66M | -5.74M | -4.18M | -3.25M | -3.09M | -1.43M | -2M | -4.78M | -5.01M | -4.77M | -3.7M | -4.23M | -2.88M | -1.97M | -2.15M | -1.29M |
Maintenance CapEx | n/a | -4.18 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.67K | -2.94K | n/a | n/a | -5.67K | -9.99K | -5.39K | n/a | -10.85K | -10.56K | n/a |
Growth CapEx | n/a | 8.36 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 50.38K | -31.72K | n/a |
Owner Earnings | -5.81M | -8.34M | -10.13M | -5.33M | -3.68M | -4.1M | -3.66M | -5.74M | -4.18M | -3.25M | -3.09M | -1.43M | -2M | -4.78M | -5.01M | -4.77M | -3.7M | -4.23M | -2.88M | -2.02M | -2.12M | -1.29M |
Add to Watchlist
Select watchlists to add or remove NGEN